Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 11/28/15  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Donald J. Hayden Jr.

Wrong Donald J. Hayden Jr.?

Chairman

Phone: (804) ***-****  
Email: d***@***.com
Insmed Incorporated
9 Deer Park Drive Suite C
Monmouth Junction , New Jersey 08852
United States

Company Description: Insmed Incorporated (Insmed) is a development stage biopharmaceutical company specializing in recombinant protein drug development. The Company also engaged the...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • Bachelor of Arts degree
  • Masters of Business Administration degree
    Indiana University
  • MBA
    Indiana University
  • BA
    Harvard University
  • B.A.
  • undergraduate degree
    Harvard University
  • M.B.A.
    Indiana University
174 Total References
Web References
Donald J. Hayden, ...
www.insmed.com, 28 Nov 2015 [cached]
Donald J. Hayden, Jr.?
...
Donald J. Hayden, Jr.? Chairman of the Board
Mr. Hayden has been a member of our Board since December 2010. Mr. Hayden has been the non-Executive Chairman of our Board since December 2010, except for the period from May 2012 to September 2012, when he acted as our Executive Chairman during a transition of senior level management. He previously served as the Executive Chairman of Transave, a biotechnology company, from 2006 until 2010, when Transave was acquired by Insmed. From 1981 to 2006, Mr. Hayden was an executive with Bristol-Myers Squibb Company, where he served in key executive roles including President of Global Pharmaceuticals; Executive Vice President and President, Americas; Executive Vice President of the Health Care Group; President of Oncology and Immunology; and Senior Vice President of Worldwide Franchise Management and Business Development. Mr. Hayden currently serves as chairman of the boards of ReGenXBIO (Nasdaq: RGNX) and Vitae Pharmaceuticals (Nasdaq: VTAE), as well as lead independent director of Amicus Therapeutics (Nasdaq: FOLD). Mr. Hayden also chairs the board of Nora Therapeutics, a privately held company, and serves as a director of Otsuka America Pharmaceuticals, Inc., the U.S. subsidiary of Otsuka Pharmaceutical Company, Limited. Mr. Hayden is a senior advisor to Prospect Venture Partners, a venture capital firm. Mr. Hayden holds a Bachelor of Arts degree in general studies from Harvard University and a Masters of Business Administration degree from Indiana University.
Donald J. Hayden ...
investor.insmed.com, 28 Nov 2015 [cached]
Donald J. Hayden Jr.
...
Donald J. Hayden Jr.
Chairman of the Board
Mr. Hayden has been a member of our Board since December 2010. Mr. Hayden has been the non-Executive Chairman of our Board since December 2010, except for the period from May 2012 to September 2012, when he acted as our Executive Chairman during a transition of senior level management. He previously served as the Executive Chairman of Transave, a biotechnology company, from 2006 until 2010, when Transave was acquired by Insmed. From 1981 to 2006, Mr. Hayden was an executive with Bristol-Myers Squibb Company, where he served in key executive roles including President of Global Pharmaceuticals; Executive Vice President and President, Americas; Executive Vice President of the Health Care Group; President of Oncology and Immunology; and Senior Vice President of Worldwide Franchise Management and Business Development. Mr. Hayden currently serves as chairman of the boards of ReGenXBIO (Nasdaq: RGNX) and Vitae Pharmaceuticals (Nasdaq: VTAE), as well as lead independent director of Amicus Therapeutics (Nasdaq: FOLD). Mr. Hayden also chairs the board of Nora Therapeutics, a privately held company, and serves as a director of Otsuka America Pharmaceuticals, Inc., the U.S. subsidiary of Otsuka Pharmaceutical Company, Limited. Mr. Hayden is a senior advisor to Prospect Venture Partners, a venture capital firm. Mr. Hayden holds a Bachelor of Arts degree in general studies from Harvard University and a Masters of Business Administration degree from Indiana University.
...
www.sec.gov, 22 Sept 2015 [cached]
0001202285 HAYDEN DONALD J JR C/O REGENXBIO INC. 9712 MEDICAL CENTER DRIVE, SUITE 100 ROCKVILLE MD 20850 1 0 0 0
"David's expertise in clinical research ...
www.otcmarkets.com, 15 Oct 2015 [cached]
"David's expertise in clinical research and development, as well as his experience advancing therapies through the regulatory process to FDA approval, will be of great value as REGENXBIO prepares to advance gene therapy treatments into the clinic," said Don Hayden, Chairman of REGENXBIO's board of directors.
...
www.sec.gov, 22 Sept 2015 [cached]
0001202285 HAYDEN DONALD J JR C/O VITAE PHARMACEUTICALS, INC. 502 WEST OFFICE CENTER DR. FORT WASHINGTON PA 19034 1 0 0 0
Other People with the name "Hayden":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304